Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Psychosis (Zuclopenthixol acetate - Psychosis)

Records returned : 4 (on 17 Jul 2025 at 21:56:39). Return to search results for ' Psychosis '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Red
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Zuclopenthixol acetate is an intermediate-acting antipsychotic formulation which should only be used on in-patient units for the short-term management of acute psychotic episodes and mania. When prescribing intramuscular zuclopenthixol, check that the prescription is clear and unambiguous in order to ensure the intended treatment is dispensed and administered.

 

 
Links :
R
Indication :
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

 
Links :
Indication :
Status :
Red
Formulations :
  • Oro-dispersible tablets
Restrictions / Comments:

Important

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

Only for use where the liquid formulation is unsuitable e.g. for supervised administration to ensure compliance.

 
Links :
R
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

Treatment resistant psychosis.

 
Links :
NFD1
SPC